Results 171 to 180 of about 81,240 (338)

Evolution of ruptured and vulnerable atheromatic plaques [PDF]

open access: gold, 2011
Rafał Wolny   +2 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

A new method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast-enhanced intravascular ultrasound and differential image analysis

open access: green, 2008
Manolis Vavuranakis   +8 more
openalex   +1 more source

Development of111In-Labeled Liposomes for Vulnerable Atherosclerotic Plaque Imaging [PDF]

open access: bronze, 2013
Mikako Ogawa   +9 more
openalex   +1 more source

Ultrasound Elastography: another piece in the puzzle of carotid plaque vulnerability?

open access: diamond, 2021
Andjoli Davidhi   +4 more
openalex   +2 more sources

The Modified Oral Status Survey Tool: Development and Psychometrics for Accessible Oral Health Data Collection

open access: yesCommunity Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives Understudied populations such as those with intellectual disabilities (ID) face significant disease burden and oral health disparities. Systematic exclusion from oral health research contributes to resultant health inequalities, limits understanding of the determinants and implications of disease, and hinders the ability to improve ...
Katrina Byrne   +4 more
wiley   +1 more source

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy